Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Circulation|May 5, 2004
Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudyIssam Moussa, Martin B Leon, Donald S Baim, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Outcomes and complications with off-label use of drug-eluting stents: results from the STENT (Strategic Transcatheter Evaluation of New Therapies) groupBruce R Brodie, Thomas Stuckey, William Downey, et al.
The New England Journal of Medicine|May 7, 2010
Everolimus-eluting versus paclitaxel-eluting stents in coronary artery diseaseGregg W Stone, Ali Rizvi, William Newman, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 23, 2012
Clinical outcomes in real-world patients with acute myocardial infarction receiving XIENCE V® everolimus-eluting stents: one-year results from the XIENCE V USA studyKrishnankutty Sudhir, James B Hermiller, Srihari S Naidu, et al.
American Heart Journal|November 26, 2013
Everolimus-eluting stents in patients undergoing percutaneous coronary intervention: final 3-year results of the Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With de Novo Native Coronary Artery Lesions trialSorin J Brener, Dean J Kereiakes, Charles A Simonton, et al.
JACC. Cardiovascular Interventions|November 26, 2011
Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized TrialsBimmer E Claessen, Pieter C Smits, Dean J Kereiakes, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Clinical and angiographic outcomes with sirolimus-eluting stents in total coronary occlusions: the ACROSS/TOSCA-4 (Approaches to Chronic Occlusions With Sirolimus-Eluting Stents/Total Occlusion Study of Coronary Arteries-4) trialDavid E Kandzari, Sunil V Rao, Jeffrey W Moses, et al.
Circulation. Cardiovascular Interventions|May 6, 2015
Stent Thrombosis and Dual Antiplatelet Therapy Interruption With Everolimus-Eluting Stents: Insights From the Xience V Coronary Stent System TrialsPhilippe Généreux, David R Rutledge, Tullio Palmerini, et al.
JAMA|May 20, 2004
Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trialGregory J Merten, W Patrick Burgess, Lee V Gray, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 4, 2019
Procedural characteristics and clinical outcomes in patients undergoing percutaneous coronary intervention for left main trifurcation disease: the EXCEL trialDavid E Kandzari, Anthony H Gershlick, Patrick W Serruys, et al.
Pageof 5